rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-1-25
|
pubmed:abstractText |
We evaluated the clinical performance of a novel cardiac troponin I (cTnI) assay specifically designed to improve the very early risk stratification in acute coronary syndromes.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0014-2972
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
112-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15667582-Aged,
pubmed-meshheading:15667582-Area Under Curve,
pubmed-meshheading:15667582-Early Diagnosis,
pubmed-meshheading:15667582-Female,
pubmed-meshheading:15667582-Humans,
pubmed-meshheading:15667582-Immunoassay,
pubmed-meshheading:15667582-Male,
pubmed-meshheading:15667582-Myocardial Infarction,
pubmed-meshheading:15667582-Risk Assessment,
pubmed-meshheading:15667582-Sensitivity and Specificity,
pubmed-meshheading:15667582-Troponin I
|
pubmed:year |
2005
|
pubmed:articleTitle |
Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept.
|
pubmed:affiliation |
Department of Medicine, University of Turku, FIN-20520 Turku, Finland. tuomo.ilva@pp.inet.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|